AIXC — Aixcrypto Holdings Share News
0.000.00%
Last trade - 00:00Qualigen Therapeutics soars on Faraday Future's $41 million crypto bet
Brief: Faraday Future Invests $41M in Qualigen to Launch Crypto Venture via PIPE Deal
Brief: Qualigen Therapeutics, Inc. Receives Expected Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Report On Form 10-Q
Brief: Univest Securities Announces Successful Closing Of $5.1 Million Private Placement For Qualigen Therapeutics
Brief: Qualigen Therapeutics Announces $4.5 Million Private Placement Of Convertible Preferred Shares
Brief: Qualigen Therapeutics - Will Implement A 1-For-50 Reverse Stock Split Of Issued Shares Of Its Common Stock
Brief: Qualigen Therapeutics Files For Offering On Reasonable Best Efforts Basis Up To 14 Million Shares Of Common Stock -SEC Filing
Brief: Qualigen Therapeutics gets Nasdaq notice on non-compliance with listing rule
Brief: Qualigen Therapeutics Announces Management Changes
Brief: Univest Securities Announces Closing Of $3.46 Mln Registered Direct Offering
Brief: Qualigen Therapeutics Announces Closing Of Public Offering
Brief: Qualigen Therapeutics Says Co Granted Until Oct 31, 2024 To Regain Compliance With Nasdaq Rules
Brief: Lifecore Biomedical Announces Cooperation Agreement With 22NW
Brief: Qualigen Therapeutics, Inc. Received Nasdaq Notice Of A Delisting Determination
Brief: Qualigen Therapeutics On Feb 15, Entered Into License And Sublicense Agreement With Pan-Ras Holdings
Brief: Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
Brief: Qualigen Therapeutics Partners With Td2 For Phase 1 Clinical Development For Treatment Of Advanced Or Metastatic Solid Tumors
Qualigen Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Qualigen-On Aug 1,Board Approved Full Reinstatement Of Base Salaries For All Executive Officers Of Co To Pre-Reduction Levels,Effective Immediately